🇺🇸

US SEC Filing Intelligence

· daily

S&P 500 Consumer Staples Sector SEC Filings — September 11, 2026

The 15 filings for the S&P 500 Consumer Staples stream reveal a sector under significant pressure from macro headwinds, with Kroger's Q2 2026 results serving as the primary signal of decelerating demand and margin compression. Identical sales growth at Kroger collapsed to 0.2% from 3.4% YoY, prompting a full-year guidance cut, while gross margins contracted 10 bps and leverage declined due to rising costs. In contrast, insider activity at Altria shows a director buying $101K in stock, a modest but positive signal of confidence. The bulk of filings (12) are routine director stock awards at Archer-Daniels-Midland, indicating no material insider trading signals but consistent board compensation. The overarching theme is a bifurcated consumer staples landscape: defensive names like Kroger face top-line stagnation and cost inflation, while tobacco and agribusiness show stable insider behavior. The key portfolio-level trend is margin compression and guidance caution, with Kroger's 140 bps headwind from the Inflation Reduction Act highlighting regulatory impacts on consumer spending. The market implication is that investors should favor companies with pricing power and cost discipline, as volume-driven growth remains elusive.

14 high priority 1 medium 15 total filings
· daily

S&P 500 Industrials Sector SEC Filings — September 11, 2026

The 7 filings for September 11, 2026, covering S&P 500 Industrials, reveal a period of quiet capital management and baseline insider activity, dominated by routine equity grants at Union Pacific (UNP) and a single insider gift at Parker-Hannifin (PH). Deere John Capital Corporation (JDCC) executed a sizable $1.8 billion debt issuance to fund commercial operations, confirming robust access to credit markets despite a mixed rate environment. Union Pacific’s string of stock awards to key C-suite and VP-level officers—including the CFO, CIO, and Marketing head—indicates standard compensation practices with no discernible insider selling, which is a neutral signal for management conviction. No forward-looking guidance adjustments, major capital allocation changes (buybacks or dividends), or M&A were reported. The overarching theme is one of operational stability, with corporations focusing on routine financing and equity-based retention rather than signaling urgency or dramatic shifts. The absence of bearish insider activity (no significant sales) and presence of a large strategic debt raise suggest a resilient, albeit unexciting, industrial sector outlook. However, the lack of period-over-period comparisons or guidance updates across these filings limits the ability to assess momentum. The only notable capital markets signal is JDCC's debt structuring, which may imply long-term investment or working capital needs at Deere's finance arm.

6 high priority 1 medium 7 total filings
· daily

US Material Events SEC 8-K Filings — September 11, 2026

The September 11, 2026, material events landscape is dominated by acute financial distress and strategic pivots, with several companies facing existential liquidity crises. America's Car-Mart and Karyopharm Therapeutics are in critical forbearance and restructuring situations, while P3 Health Partners is resorting to a 19.5% preferred stock issuance, signaling severe capital constraints. Conversely, a significant capital market event is the $1.0 billion equity raise by Oklo Inc., which fully exhausted its prior ATM facility, indicating strong investor appetite for high-growth energy stories. The period is also marked by a wave of executive departures, with CFOs resigning at TransCode, Citi Trends, Peraso, and CleanCore, among others, creating operational uncertainty. A notable positive development is the merger of Korsana Biosciences with Cyclerion, backed by a $380 million private placement, providing a substantial cash runway into 2029. The overall theme is a bifurcated market where cash-rich, high-growth companies can access capital easily, while distressed entities face a rapidly closing window for refinancing.

50 high priority 50 total filings
· daily

Insider Trading Pulse — September 11, 2026

The September 11, 2026 insider trading digest reveals a bifurcated market with aggressive insider buying in select small/mid-cap names and systematic selling by executives at several growth and technology companies. The most significant buying signals come from Angel Studios ($1.88M director purchase), GROUP 1 AUTOMOTIVE ($6.62M 10% owner accumulation), and RELMADA THERAPEUTICS ($505K CFO + $418K CEO purchases), indicating strong management conviction in undervalued assets. Conversely, Sea Ltd executives executed coordinated sales totaling over $4.3M under 10b5-1 plans, while SERA PROGNOSTICS saw four officers sell simultaneously at $2.00/share, suggesting sector-specific headwinds. Notable insider pledges at JAKKS PACIFIC across five directors raise governance concerns. The data shows a clear pattern of capital flowing into companies with tangible assets and near-term catalysts, while insiders reduce exposure in high-growth names facing margin compression.

49 high priority 1 medium 50 total filings
· daily

Dow Jones 30 Stocks SEC Filings — September 11, 2026

Today's Dow 30 filings are dominated by routine director stock awards at Microsoft and a single insider sale at Home Depot, resulting in a low overall materiality profile. The 11 Microsoft filings all involve standard director compensation in restricted stock units (RSUs), reflecting a neutral sentiment and no actionable trading signals from insiders. The lone bearish signal comes from Home Depot, where the SVP-Finance, CAO & Controller sold 675 shares (~$207K), a transaction that is small relative to total holdings but notable as the only insider sale in the batch. No period-over-period comparisons, forward-looking guidance, capital allocation changes, or M&A activity were present in any filing, limiting the depth of trend analysis. The key takeaway is the absence of material corporate developments across these blue-chip constituents, suggesting a quiet period for Dow 30 insider activity and corporate events. Investors should monitor for any subsequent filings that could provide context to the Home Depot sale, but overall, this batch offers no immediate catalysts or red flags.

2 high priority 10 medium 12 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — September 11, 2026

On September 11, 2026, three US micro-cap companies received Nasdaq deficiency notices for failing to maintain the $1.00 minimum bid price, creating a concentrated distress event in the small-cap equity space. Fractyl Health (GUTS) faces immediate delisting after exhausting its 180-day grace period and is pursuing a reverse stock split (1-for-5 to 1-for-15) to regain compliance. Greenland Technologies (GTEC) secured a second 180-day extension until March 8, 2027, providing temporary relief but highlighting persistent structural weakness. Glimpse Group (BTLN) received a final delisting determination and has only until September 18 to appeal, creating the most time-sensitive risk. All three companies share a common distress pattern: prolonged sub-$1 trading, reliance on reverse stock splits as a remedy, and uncertain outcomes pending Nasdaq hearings. The cluster of filings on a single day suggests a broader market rotation away from micro-cap names with weak fundamentals, as no company reported positive period-over-period revenue growth or insider buying in the enriched data. The absence of any capital allocation actions (dividends, buybacks) across all three filings confirms severe financial constraints, with management teams focused entirely on survival rather than shareholder returns.

3 high priority 3 total filings
· daily

Global High-Priority Regulatory Events — September 11, 2026

The September 11, 2026 digest reveals a market dominated by significant restructuring and distress events, with a clear bifurcation between successful turnarounds and escalating failures. The most critical development is New Fortress Energy's completion of a massive restructuring that extinguished ~$5.7 billion in debt, representing a landmark event in the energy sector. Insolvency and CIRP resolutions are accelerating, with Diamond Power Infrastructure completing its resolution one year early and VXL Instruments approving a plan that wipes out equity holders. The SPAC market shows extreme stress, with Ribbon Acquisition Corp experiencing a 68.1% redemption rate, while several companies face imminent delisting threats from Nasdaq bid price non-compliance. A concerning pattern of cyber fraud has emerged, with Lancer Container Lines losing ₹53 lakhs in a social engineering attack. Period-over-period trends are limited in these event-driven filings, but the aggregate data shows a clear pattern of distressed companies seeking emergency capital structure solutions through mergers, reverse stock splits, and debt restructuring.

40 high priority 40 total filings
· daily

US SEC Filings Daily Market Digest — September 11, 2026

Today's filings reveal a market bifurcated between operational turnarounds and persistent financial strain. Hooker Furnishings posted a $4.9M swing to profitability driven by tariff recoveries, while LightPath Technologies saw revenue surge 93% YoY yet its net loss widened to $20.5M, highlighting the cost of hypergrowth. The SPAC space remains active with three new business combination filings (Graf Global/BIG3, Research Alliance III/Oak Hill Bio, DTSQ/Primegen), signaling continued appetite for public market debuts despite a mixed macro backdrop. Insider selling at Sea Ltd by three top executives for a combined ~$4.2M under 10b5-1 plans contrasts with a major insider accumulation at Evogene (1.26M shares bought). Debt management is a key theme: Impinj reduced its 2027 notes by $56.3M, while Wynn Resorts added $900M in high-coupon debt (6.875%) and Nauticus Robotics extended $4M in convertible debentures, reflecting divergent credit profiles. The most actionable trend is the convergence of space and biotech in SPAC mergers, alongside a clear signal that companies with tariff or regulatory tailwinds (Hooker, LightPath) are outperforming those with operational headwinds (MoneyHero, Braskem).

21 high priority 29 medium 50 total filings
· daily

S&P 500 Consumer Discretionary Sector SEC Filings — September 11, 2026

The single filing from Home Depot, Inc. on September 11, 2026, reveals a notable insider sale by the SVP-Finance, CAO & Controller, Kimberly R. Scardino, who sold 675 shares at $305.95, totaling approximately $207,000. While the sale is relatively small in magnitude (materiality 3/10), it carries a negative sentiment, potentially signaling a lack of conviction at the executive level. No other enriched data fields (period comparisons, forward-looking statements, capital allocation, etc.) were available for this filing, limiting the ability to identify broader sector trends. The absence of additional filings from other S&P 500 Consumer Discretionary companies on this date restricts cross-company analysis. However, the insider sale warrants monitoring for any follow-on transactions or broader insider selling patterns within the retail/home improvement sector.

1 high priority 1 total filings
· daily

S&P 500 Healthcare Sector SEC Filings — September 11, 2026

Today's healthcare insider filings cluster heavily around tax-related share withholding and planned sales, signaling routine compensation management rather than directional conviction. Excluding three unparseable Gilead filings and one low-materiality gift by Eli Lilly's EVP of Quality, we observe seven actionable insider events, with only two involving open-market sales — both under 10b5-1 plans. Notably, Intuitive Surgical's EVP of Manufacturing sold shares at $365.79 (gain of ~5.2% from his exercise price), while Edwards Lifesciences' CVP of TAVR realized a ~20% gain on option exercise and sale at $87.51. No bullish insider buying was recorded, and zero forward-looking guidance, earnings calls, or capital allocation changes were flagged in these Form 4-only filings. The absence of period-over-period financial comparisons or operational metrics limits portfolio-level trend analysis, but the sector's insider selling pattern — especially in med-tech names trading near multi-year highs — warrants caution as we enter Q4 2026. With no guidance revisions or M&A catalysts in the batch, the digest's actionable intelligence centers on two wealth-transfer signals: Edwards' manageable tax withholding and Eli Lilly's tax-efficient gift structuring.

9 high priority 9 total filings
· daily

US Earnings Financial Results SEC Filings — September 11, 2026

The 26 filings reveal a bifurcated market: high-growth tech and aerospace companies (Oracle, Guidewire, Butler National) are delivering strong revenue and margin expansion, while consumer-facing and commodity-linked businesses (1-800-Flowers, Mesabi Trust, AMREP) face significant headwinds. Notable trends include a surge in cloud/AI-driven capital expenditure (Oracle's capex up to $28.5B), margin improvement in specialty retail (Vince, Rent the Runway), and a sharp deterioration in credit quality at Southern Missouri Bancorp. Several micro-cap and shell companies (IWAC, APEX 11, Hawkeye) remain pre-revenue with minimal cash, posing high risk. Insider activity is sparse, but capital allocation signals are mixed: dividend cuts at Hooker Furnishings and Mesabi Trust contrast with new dividends at Coffee Holding and continued buybacks at Butler National. Forward-looking data points to continued investment in AI infrastructure and potential catalysts in uranium and gold exploration.

26 high priority 26 total filings
· daily

US Executive Compensation Proxy SEC Filings — September 11, 2026

This intelligence stream covers 11 proxy filings, revealing a landscape dominated by corporate actions requiring shareholder approval: two major M&A-driven advisory agreement changes (Russell Investments entities), a transformative all-stock merger (Supernus/Indivior), and several capital structure proposals (Annovis Bio's share increase, aTyr Pharma's reverse split). The filings show no direct period-over-period financial comparisons or insider trading activity, as these are governance documents. Key themes include significant dilution risk for Annovis Bio shareholders, a high-conviction all-stock merger for Supernus with no cash component, and the $2.8B Russell Investments acquisition creating a new governance structure. The most material developments are the Supernus merger (materiality 9/10) and the Russell Investments change-of-control events (materiality 8/10), which create clear catalysts and timelines for investors. The filings also highlight governance trends such as board refreshment (Wolfspeed) and equity incentive plan expansions.

11 high priority 11 total filings
· daily

US IPO Pipeline SEC S-1 Filings — September 11, 2026

The IPO pipeline for September 11, 2026, is dominated by SPAC and de-SPAC activity, with 4 of 10 filings involving blank-check companies or business combinations, signaling continued appetite for alternative listing routes. However, the quality of traditional IPOs is mixed: Barrel Energy and Eloxx Pharmaceuticals both filed S-1s with deteriorating financials—Barrel Energy saw revenue decline 9.8% YoY and net income plunge 96%, while Eloxx has never generated product revenue and relies on debt. NuCube Energy's $500 million de-SPAC valuation stands out as the largest transaction, though no period comparisons were provided. Insider activity is absent across all filings, limiting conviction signals, but capital allocation patterns reveal distress: Barrel Energy has negative working capital and an accumulated deficit of $310K, and Rent the Runway is conducting a rights offering at a minimum $3.55/share with a backstop, alongside a $9 million class action settlement. A key portfolio-level trend is the prevalence of 'mixed' sentiment filings (3 of 10), reflecting uncertainty around valuations, regulatory approvals, and post-merger viability. The pipeline lacks high-growth, revenue-positive companies, suggesting a risk-off tone among issuers.

10 high priority 10 total filings
· daily

US SEC Trading Suspension Halt Orders — September 11, 2026

All three filings concern Nasdaq minimum bid price compliance failures, signaling a cluster of micro-cap distress driven by sustained sub-$1.00 share prices. Fractyl Health (GUTS) faces imminent delisting after exhausting its 180-day grace period, but has proposed a reverse stock split (1-for-5 to 1-for-15) and will request a hearing to stay the delisting. Greenland Technologies (GTEC) received a second 180-day extension until March 8, 2027, providing temporary relief but with continued delisting risk if compliance is not achieved. Glimpse Group (BTLN) received a Staff Determination to delist, with an appeal deadline of September 18, 2026, and plans to request a hearing. All three companies are considering or have proposed reverse stock splits as a remedy, a common but often ineffective strategy that can trigger further declines. The cluster suggests a broader trend of micro-cap liquidity and valuation pressures, with no positive period-over-period trends or insider buying to offset the negative outlook.

3 high priority 3 total filings
· daily

US Executive Officer Management Changes SEC — September 11, 2026

The September 11, 2026, digest reveals a high volume of executive and director changes, with 32 filings processed. A key theme is the prevalence of voluntary departures and retirements, often with no disclosed disagreements, suggesting routine churn but also potential underlying talent retention challenges. Notable negative signals include a sharp 94.1% decline in net income at AMREP Corp. and a contentious board resignation at BioRestorative Therapies triggering a potential $1.29 million severance dispute. Positive developments include strategic leadership restructuring at Celestica to capitalize on 'unprecedented growth' and the appointment of a seasoned CFO at Oportun Financial. Insider activity is limited, but shareholder dissent on equity plan amendments at NetScout Systems and Artiva Biotherapeutics signals governance concerns. The data suggests a bifurcated market where strong companies are proactively restructuring for growth, while others face operational and governance headwinds.

32 high priority 32 total filings
· daily

US Corporate Board Director Changes SEC Filings — September 11, 2026

Today's USA Board Room Changes digest reveals a high volume of CFO and C-suite departures, with 12 officer changes across 32 filings, signaling potential operational instability at several firms. Notable trends include a wave of CFO transitions at Celestica, Oportun, and Coty, where internal promotions and strategic restructurings suggest proactive succession planning. However, several filings carry negative sentiment, including a disputed resignation at BioRestorative Therapies triggering a $1.29M severance claim and a 94% net income plunge at AMREP. Insider activity is sparse, but shareholder dissent on equity plan amendments at Artiva Biotherapeutics (17.3% against) and Peraso (38.6% against) flags governance concerns. The mix of routine retirements and sudden exits creates a bifurcated landscape of stable leadership transitions versus high-risk governance disruptions.

32 high priority 32 total filings
· daily

USA Insider Trading Pulse — September 11, 2026

The September 11, 2026 insider trading pulse reveals a market with divergent insider sentiment: a cluster of high-conviction insider buying in small-cap and micro-cap names (Relmada Therapeutics, Angel Studios, Group 1 Automotive) contrasts with significant, pre-planned selling in high-growth tech (Sea Ltd, Zoom Communications) and insider selling in struggling healthcare (Sera Prognostics). A notable pattern is the coordinated option exercise and pledge activity at JAKKS Pacific, which may signal capital management rather than directional conviction. The data shows a clear sector divide: life sciences and select financials are seeing insider accumulation, while consumer tech and micro-cap diagnostics are experiencing insider distribution. The most actionable signals come from the magnitude of insider purchases at Angel Studios ($1.88M) and Group 1 Automotive ($6.62M), which dwarf other transactions and suggest strong fundamental conviction. Overall, the pulse indicates selective opportunity in beaten-down sectors with insider support, while caution is warranted for names with persistent 10b5-1 selling programs.

49 high priority 1 medium 50 total filings
· daily

US Merger & Acquisition SEC Filings — September 11, 2026

The September 11, 2026, filing batch reveals a bifurcated M&A landscape: high-conviction de-SPAC mergers (Cyclerion/Korsana, Athena/Ace Green) are closing with strong shareholder support and significant capital raises, while several SPACs (Ribbon, Quetta, Columbus) are showing signs of distress with massive redemptions, repeated extensions, and adjournments. The most transformative event is New Fortress Energy's restructuring, which extinguished ~$5.7B in debt and created two standalone entities, representing a massive balance sheet repair. A notable cross-border deal emerged with ChampionsGate's $80M EV acquisition of Korean safety diagnostics firm Futuremain, while Volato's amended merger with Aligned Engine at a $500M valuation shows deal terms are being renegotiated upward. The data reveals a clear pattern: SPACs with strong institutional backing and tangible assets are closing successfully, while those without are struggling to maintain trust account balances. Period-over-period comparisons show no revenue trends as most filers are pre-revenue SPACs or restructuring entities, but the capital allocation trends are stark—$475M in new cash for Korsana vs. $36.3M in redemptions draining Ribbon's trust.

19 high priority 19 total filings
· monthly

US Pre-Market SEC Filings Roundup — September 11, 2026

The overnight filing set presents a mixed picture for U.S. markets, characterized by significant insider selling at high-growth biotechs and a wave of capital structure changes. A key macro theme is the growing financial strain in the biotechnology sector, with CEOs at Protagonist Therapeutics and Roivant Sciences executing large pre-planned stock sales, while Nauticus Robotics secures a one-year debt extension, signaling ongoing cash burn. Conversely, industrial and technology companies like LightPath Technologies and Descartes Systems Group are reporting robust revenue growth driven by secular tailwinds (defense, supply chain logistics). Notable capital markets activity includes a $1.3 billion dual-tranche debt offering by Thomson Reuters and a $900 million high-yield issuance by Wynn Resorts, contrasting with a $56.5 million debt-for-equity exchange at Impinj. A prominent sector theme is the continued activity in the SPAC market, with several filings advancing de-SPAC mergers with companies in biotech (Oak Hill Bio) and space technology (Gravitics), alongside a proposed public listing of the BIG3 basketball league.

24 high priority 26 medium 50 total filings
· daily

Federal Construction & Infrastructure Contracts — September 10, 2026

This digest covers three civilian federal construction contracts totaling $177.6 million, with zero defense exposure, signaling a concentrated investment opportunity in non-defense infrastructure. The dominant theme is Department of the Interior water and park infrastructure spending, led by a $72.9 million Bureau of Reclamation pipeline award to Carstensen Contracting Inc., which represents the highest-conviction signal due to its materiality and alignment with long-term water resource priorities. A key risk is the fixed-price nature of all three contracts, which exposes contractors to cost-overrun risk, particularly for Record Steel and Construction's $46.2 million Yellowstone water treatment project, where only 15% of funds have been outlayed. Investors should monitor option exercises and outlay rates as leading indicators of execution quality and cash flow.

3 total filings